Marker Therapeutics sets 2026 annual meeting for May 1; shareholder proposals due March 9

Marker Therapeutics, Inc.

2026 Annual Meeting scheduled for May 1, 2026, moving more than 30 days from 2025 meeting date.
Shareholder proposals under Rule 14a-8 must be received by March 9, 2026, at company's Houston offices.
Record date and meeting details to be included in the upcoming proxy statement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.